In a crucial update for international travelers from Madhya Pradesh, the All India Institute of Medical Sciences (AIIMS) in Bhopal has confirmed that the Yellow Fever vaccine remains readily available at its facility. This clarification comes after a recent online notice had caused confusion among the public regarding the vaccine's stock status.
Vital Travel Requirement Clarified
The Yellow Fever vaccine is a mandatory health requirement for entry into nearly 42 countries across Africa and South America. AIIMS Bhopal stands as the sole authorized centre in the entire state of Madhya Pradesh to administer this critical vaccine. Each week, an estimated two dozen international travelers visit the institute to receive this vaccination, which is essential for those travelling abroad for purposes of education, work, or tourism.
Addressing the Confusion
The institute released a press statement on Wednesday to set the record straight. Officials emphasized that the vaccine has always been in stock and continues to be administered without interruption. This statement serves as a direct clarification following a public notice dated July 10 that appeared on the institute's official website, which incorrectly stated that the centre had no stock of the Yellow Fever vaccine. Institute authorities have now clarified that this earlier website notice was misleading and that the vaccine was never unavailable.
Ensuring Smooth International Travel
As the only provider of this service in Madhya Pradesh, AIIMS Bhopal plays an indispensable role in the visa processing pipeline for countless individuals. Without this vaccination, travelers risk having their visa applications rejected or facing entry bans in the destination countries. The institute's reaffirmation of stock availability ensures that students, professionals, and tourists from the region can proceed with their travel plans confidently, without any medical hurdles.
